three
peptid
amino
acid
residu
aa
tm
aa
correspond
spike
protein
sever
acut
respiratori
syndrom
corona
viru
sar
cov
synthes
immunolog
function
investig
three
differ
anim
model
mice
guinea
pig
rabbit
peptid
mixtur
formul
either
freund
adjuv
synthet
adjuv
montanid
nucleotid
cpg
isacpg
could
elicit
antisera
immun
anim
capabl
inhibit
sarshiv
pseudoviru
entri
cell
neutral
epitop
identifi
use
peptid
block
neutral
effect
guinea
pig
antisera
major
neutral
epitop
locat
peptid
amino
acid
residu
fine
map
balbc
mice
tcell
prolifer
assay
reveal
peptid
contain
tcell
epitop
sequenc
correspond
amino
acid
residu
isacpg
formul
gener
igg
titer
compar
obtain
freund
adjuv
formul
gener
fewer
antibodi
tm
peptid
highli
immunogen
peptid
contain
neutral
th
cell
epitop
result
suggest
synthet
peptid
would
use
compon
sar
vaccin
candid
emerg
infecti
diseas
caus
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
signific
econom
impact
countri
affect
diseas
outbreak
sinc
licens
sar
vaccin
risk
pose
worldwid
outbreak
sar
futur
still
exist
urgent
need
find
safe
effect
sar
vaccin
futur
use
sar
vaccin
candid
could
develop
use
inactiv
viru
attenu
viru
recombin
synthet
viral
compon
latter
approach
particularli
attract
reduc
risk
involv
work
potenti
hazard
live
organ
moreov
fulli
synthet
peptid
deriv
immunogen
region
viral
compon
could
provid
welldefin
immunogen
may
easili
compli
regulatori
requir
appropri
select
major
reactiv
epitop
correspond
peptid
vaccin
design
crucial
success
increas
knowledg
viral
entri
mechan
antigen
structur
viral
protein
great
help
peptidebas
vaccin
develop
spike
protein
develop
vaccin
candid
induc
humor
cellular
immun
mous
model
spike
protein
sar
cov
compris
amino
acid
play
import
role
recognit
bind
host
receptor
angiotensin
convert
enzym
receptor
bind
motif
local
amino
acid
residu
protein
believ
viru
bind
could
induc
conform
chang
spike
protein
form
trimerofhairpin
organ
see
front
matter
elsevi
inc
character
fusion
core
structur
fusion
core
contain
two
highli
conserv
heptad
repeat
hr
region
believ
facilit
viruscel
fusion
predict
region
local
amino
acid
residu
respect
previous
found
import
neutral
epitop
aa
locat
front
region
zeng
et
al
found
neither
antibodi
sl
alon
could
neutral
viru
antibodi
gener
region
spike
protein
could
block
hostcel
viral
entri
import
includ
differ
function
domain
design
effect
peptidebas
vaccin
studi
analyz
abil
synthet
peptid
serv
vaccin
candid
assess
abil
elicit
antibodi
respons
inhibit
function
essenti
domain
viru
bind
entri
import
induct
peptidespecif
immun
respons
also
investig
immunolog
function
two
potenti
human
use
adjuv
montanid
oligodeoxynucleotid
cpg
peptid
use
studi
deriv
ntermin
spike
protein
aa
receptorbind
region
spike
protein
aa
region
overlap
region
spike
protein
tm
aa
three
peptid
mix
adjuv
studi
immunogen
differ
anim
previous
develop
pseudoviru
sarshiv
model
use
determin
neutral
abil
peptidesinduc
antisera
immunolog
domin
tcell
epitop
identifi
mous
model
peptid
sar
cov
spike
protein
peptid
use
map
neutral
epitop
tcell
epitop
synthes
amino
acid
overlap
entir
cover
spike
protein
sequenc
supplementari
data
product
peptidespecif
antisera
mice
immun
subcutan
lg
peptid
tm
emulsifi
complet
freund
adjuv
cfa
amount
synthet
peptid
emulsifi
incomplet
freund
adjuv
ifa
use
boost
immun
day
initi
immun
guinea
pig
rabbit
immun
lg
peptid
formul
adjuv
respect
immun
protocol
use
describ
moreov
adjuv
montanid
lg
cpg
nucleotid
tcg
tcg
ttt
tgt
cgt
ttt
gtc
gtt
ttg
tcg
tt
equival
volum
lg
peptid
mixtur
subcutan
inject
mice
use
immun
protocol
antisera
collect
immunolog
biolog
assay
everi
two
week
second
boost
antibodi
titer
determin
elisa
tcell
prolifer
assay
determin
whether
peptid
immunogen
could
induc
specif
tcell
lymphoprolif
respons
onehundr
microlit
cellsml
splenocyt
complet
cultur
medium
rpmi
supplement
heatinactiv
fetal
calf
serum
ad
well
plate
peptid
ad
well
final
concentr
lgml
cell
well
cultur
total
volum
medium
day
cultur
cell
puls
h
thymidin
lciwel
h
cell
harvest
incorpor
radioact
determin
top
count
scintil
counter
packard
usa
ifnc
secret
tcell
subset
stain
tcell
purifi
immunomagnet
separ
use
minimac
system
briefli
spleen
cell
wash
resuspend
fac
buffer
bsapb
incub
microbead
separ
ls
column
accord
manufactur
instruct
cell
mix
number
mitomycin
ctreat
splenocyt
antigen
present
cell
presenc
absenc
peptid
lgml
two
day
later
cell
harvest
infc
secret
cell
identifi
use
mous
ifnc
secret
assay
detect
kit
miltenyi
biotec
germani
neutral
sar
pseudoviru
infect
sar
pseudoviru
prepar
previous
describ
supernat
contain
pseudoviru
bear
sar
cov
protein
harvest
posttransfect
use
singl
cycl
infect
cell
infect
cell
lyse
express
luciferas
activ
determin
ad
substrat
detect
luminesc
topcount
neutral
inhibit
calcul
equat
neutral
inhibit
unit
luminesc
antiserum
peptid
unit
luminesc
antiserum
unit
luminesc
without
antiserum
unit
luminesc
antiserum
statist
analysi
statist
signific
differenti
find
experiment
group
anim
determin
student
test
differ
consid
statist
signific
valu
p
order
test
immunogenec
three
peptid
tm
mix
equal
amount
lg
peptid
formul
either
cfaifa
isacpg
three
immun
lg
peptid
per
dose
peptidespecif
antibodi
respons
measur
use
peptidespecif
elisa
result
shown
tabl
among
three
peptid
seem
immunodomin
antibodi
titer
peptid
cfaifa
isacpg
group
respect
low
level
tabl
reactiv
antisera
synthet
peptid
sar
cov
spike
protein
preimmun
titer
subtract
postimmun
titer
b
eight
mice
per
group
use
immunogen
studi
reactiv
titer
express
mean
titer
obtain
eight
mice
c
four
guinea
pig
per
group
use
immunogen
studi
reactiv
titer
express
mean
titer
obtain
four
guinea
pig
four
rabbit
per
group
use
immunogen
studi
reactiv
titer
express
mean
titer
obtain
four
rabbit
antibodi
peptid
found
mice
immun
peptid
mixtur
formul
adjuv
cfaifa
isacpg
antibodi
titer
respect
moder
level
antitm
titer
found
cfaifa
isacpg
group
respect
antisera
rabbit
show
similar
antibodi
titer
tm
respect
antisera
guinea
pig
show
good
antibodi
titer
tm
respect
result
show
guinea
pig
gener
higher
antibodi
titer
tm
compar
obtain
rabbit
mice
use
pseudotypebas
neutral
assay
analyz
biolog
function
antipeptid
antisera
obtain
anim
immun
peptid
shown
fig
neutral
antibodi
induc
mice
immun
cfaifa
isacpg
formul
dilut
sera
could
inhibit
luciferas
activ
either
cfa
ifa
group
isacpg
group
tenfold
dilut
anti
peptid
sera
could
inhibit
luciferas
activ
guinea
pig
antisera
dilut
could
inhibit
luciferas
activ
fig
antisera
rabbit
could
inhibit
luciferas
activ
dilut
fig
result
indic
antibodi
elicit
peptidebas
immun
abl
block
viru
entri
neutral
effect
antipeptid
sera
strongli
inhibit
presenc
peptid
moder
inhibit
presenc
tm
mildli
inhibit
presenc
peptid
fig
peptid
could
disrupt
neutral
effect
antisera
indicat
ing
major
neutral
epitop
like
locat
peptid
region
order
map
major
neutral
epitop
use
peptid
correspond
peptid
shown
fig
found
peptid
could
inhibit
neutral
effect
antisera
respect
result
indic
amino
acid
residu
contain
major
linear
neutral
epitop
tcell
respons
splenocyt
analyz
day
last
immun
two
adjuv
formul
cfaifa
isacpg
compar
balbc
mice
individu
peptid
test
use
h
thymidin
incorpor
assay
signific
respons
tm
stimul
group
contrast
peptid
could
significantli
stimul
tcell
prolifer
cfaifa
isacpg
formul
fig
identifi
tcell
epitop
locat
immun
peptid
splenocyt
immun
mice
restimul
vitro
use
individu
peptid
list
supplementari
data
signific
prolifer
compar
si
valu
respect
peptid
ttest
p
result
suggest
presenc
one
tcell
epitop
peptid
locat
amino
acid
residu
fig
analysi
supernat
stimul
cell
ifnc
elisa
yield
consist
result
fig
ifnc
concentr
isa
cpg
group
compar
cfaifa
group
vs
altern
stimul
effect
peptid
could
due
antigen
process
gener
reactiv
epitop
order
determin
tcell
reactiv
epitop
four
peptid
synthes
base
websit
comput
program
syfpeithi
supplementari
data
peptid
predict
recogn
mhc
molecul
four
peptid
cultur
splenocyt
supernat
collect
analyz
ifnc
elisa
result
show
peptid
could
induc
ifnc
secret
fig
signific
differ
ifnc
secret
cfaifa
isa
cpg
group
vs
confirm
mhc
class
irestrict
peptid
use
purifi
tcell
identifi
respond
tcell
subset
tcell
separ
use
magnet
bead
yield
puriti
enrich
tcell
subset
greater
data
shown
mitomycin
ctreat
splenocyt
ad
antigen
present
cell
ifnddsecret
tcell
analyz
flowcytometri
result
show
peptid
peptid
could
stimul
tcell
secret
ifnc
fig
indic
peptid
also
stimul
prolifer
tcell
tcell
th
epitop
locat
amino
acid
residu
sar
cov
spike
protein
play
import
function
role
viral
infect
approach
vaccin
develop
studi
design
peptid
deriv
differ
domain
spike
protein
strategi
effici
use
singl
neutral
epitop
sinc
peptid
cocktail
could
potenti
provid
th
epitop
enhanc
immun
respons
use
peptid
cocktail
immun
mice
guinea
pig
rabbit
mous
model
also
use
adjuv
isacpg
could
potenti
use
human
vaccin
studi
immunogen
peptid
vaccin
candid
studi
also
identifi
synthet
peptid
locat
receptorbind
region
contain
b
cell
tcell
epitop
mice
peptid
aa
highli
hydrophil
region
ntermin
domain
sar
cov
spike
protein
unexpectedli
found
region
low
antigen
mice
moder
antigen
guinea
pig
rabbit
peptid
may
therefor
good
candid
vaccin
develop
receptorbind
domain
identifi
thesar
cov
spike
protein
aa
furthermor
base
crystal
structur
minimum
receptorbind
motif
spike
protein
suggest
locat
amino
acid
residu
peptid
within
bind
motif
found
highli
antigen
immunogen
mice
guinea
pig
rabbit
neutral
epitop
locat
amino
acid
residu
identifi
use
pseudoviru
entri
assay
furthermor
previou
collabor
shih
et
al
also
found
monoclon
antibodi
could
block
pseudoviru
entri
bind
epitop
locat
region
aa
import
region
previous
describ
et
al
yi
et
al
result
indic
peptid
could
good
vaccin
candid
tcell
epitop
map
use
overlap
peptid
identifi
reactiv
epitop
peptid
stimul
tcell
prolifer
h
thymidin
incorpor
assay
also
found
peptid
stimul
tcell
secret
ifnc
result
demonstr
amino
acid
residu
contain
neutral
b
cell
th
cell
epitop
studi
b
tcell
respons
hla
transgen
mice
investig
potenti
use
human
vaccin
need
order
facilit
clinic
applic
peptid
synthes
studi
formul
two
adjuv
cpg
potenti
use
human
found
isacpg
formul
show
adjuv
effect
b
tcell
respons
compar
ifacfa
formul
fig
result
indic
isacpg
formul
could
use
adjuv
develop
peptidebas
vaccin
previou
studi
found
n
protein
sar
cov
formul
isa
cpg
could
enhanc
immunogen
immun
respons
bias
toward
immun
studi
observ
similar
immun
respons
peptid
formul
isa
cpg
data
shown
may
due
need
differ
cpg
dose
n
protein
peptid
bia
toward
immun
respons
optim
cpg
dose
formul
peptidebas
vaccin
need
conclus
result
indic
peptid
cocktail
could
elicit
effici
immun
respons
mice
guinea
pig
rabbit
increas
antibodi
level
result
immun
could
block
pseudoviru
entri
preliminari
inform
obtain
peptidebas
vaccin
studi
suggest
possibl
neutral
epitop
viral
protein
also
could
possibl
use
peptid
synthes
studi
drug
mimic
viral
protein
interact
cell
membran
anim
immun
studi
includ
neutral
epitop
peptid
cocktail
form
basi
sar
vaccin
develop
human
need
financi
support
nation
scienc
council
taiwan
grant
studi
grate
acknowledg
